Purchase Order HHSP284201800152A
Award Date 2/1/18
Potential Completion Date 2/2/18
Potential Value $159K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beverly, MA 01915, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
- This firm-fixed price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies, testing components, and other products to support biosurveillance and COVID-19 testing efforts. The contract has a ceiling value of $165,918.73 and a completion date of March 12, 2018. It does not utilize any set-aside designations. Qiagen Beverly has received similar prime contracts from HHS...
- This is a $165,197.49 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer. The contract is for the provision of lab supplies, with no set-aside designation. Past awards to Qiagen Beverly, LLC have primarily supported the HHS BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This includes purchase orders for BioWatch...
- The Department of Health and Human Services (HHS) awarded a $331,000.00 Firm Fixed Price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for the provision of lab supplies. This award is not associated with any set-aside designation. Qiagen Beverly, LLC has previously received awards from HHS and the Department of the Air Force Materiel Command to provide products and services in support of the BioWatch program, a nationwide biosurveillance system to detect the...
- This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
- This $231,000 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, on April 21, 2022. The contract is for the provision of inventory in support of the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. Qiagen Beverly, LLC, which does business as Qiagen Beverly Inc., is a subsidiary of the parent company Qiagen N.V. No...
- This is a $148,157.70 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for other unspecified functions and does not have a set-aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under...
- The U.S. Department of Health and Human Services (HHS) awarded a $34,396.56 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award, which does not have a set-aside designation, is for the provision of various products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
- This federal contract award was made to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $6,218.89 firm-fixed-price purchase order was issued by the Department of Health and Human Services (HHS) with a period of performance ending on March 29, 2016. The contract did not have a set-aside designation. Qiagen is a provider of sample and assay technologies supporting federal biomedical research, public health, law enforcement, and healthcare programs. Under this...